Pediatric Brain Tumor Consortium (PBTC)-055: A phase I study of trametinib and hydroxychloroquine (HCQ) for BRAF-fusion or neurofibromatosis type-1 (NF1)-associated pediatric gliomas Meeting Abstract

  

Authors:	Hoffman, L. M.; Levy, J. M.; Kilburn, L.; Billups, C.; Stokes, V.; McCourt, E.; Poussaint, T. Y.; Campagne, O.; Partap, S.; Dorris, K.; Sait, S. F.; Robinson, G.; Baxter, P.; Stewart, C. F.; Fangusaro, J.; Onar-Thomas, A.; Dunkel, I.
Abstract Title:	Pediatric Brain Tumor Consortium (PBTC)-055: A phase I study of trametinib and hydroxychloroquine (HCQ) for BRAF-fusion or neurofibromatosis type-1 (NF1)-associated pediatric gliomas
Meeting Title:	20th International Symposium on Pediatric Neuro-Oncology (ISPNO 2022)
Journal Title:	Neuro-Oncology
Volume:	24
Issue:	Suppl. 1
Meeting Dates:	2022 Jun 12-15
Meeting Location:	Hamburg, Germany
ISSN:	1522-8517
Publisher:	Oxford University Press
Date Published:	2022-06-01
Start Page:	i35
Language:	English
ACCESSION:	WOS:000840122400131
PROVIDER:	wos
DOI:	10.1093/neuonc/noac079.129
Notes:	Meeting Abstract: EPCT-01 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/198990